Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma
Clinical trial NCT03287050 · TERMINATED
Trial details
- NCT number
- NCT03287050
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-24
- Primary completion
- 2019-03-13
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.